title: Applicability of Generic Assays Based on Liquid Chromatography-Electrospray Mass Spectrometry to Study in vitro Metabolism of 55 Structurally Diverse Compounds.
abstract: Liquid chromatography-mass spectrometry (LC-MS) with generic gradient elution for a large number of chemically different compounds is a common approach in drug development, used to acquire a large amount of data in a short time frame for drug candidates. The analysis with non-optimized parameters however may lead to a poor method performance for many compounds, and contains a risk of losing important information. Here, generic electrospray time of flight (ESI-TOF) MS methods in various pH conditions were tested for 55 chemically diverse compounds (10 acids, 25 bases, 17 neutrals, and 3 amphoterics), aiming to find best analytical conditions for each compound, for studies of in vitro metabolic properties in liver preparations. The effect of eluent pH and elution gradient strength on chromatographic performance and electrospray MS ionization efficiency were examined for each compound. The data are evaluated how well the best generic approach could cover the analysis of test compounds and how many compounds would still need completely different analytical conditions after that. Aqueous mobile phase consisting of 0.05% acetic acid and 5 mM ammonium acetate (pH 4.4) showed the best general suitability for the analyses, showing adequate performance for metabolite profiling for 41 out of 55 compounds either in positive or negative ion mode. In positive ion mode, the main limitation of performance in various pH conditions was generally not the lack of ionization, but rather the poor chromatographic performance (inadequate retention or poor peak shape), suggesting that more emphasis should be put in finding conditions providing best chromatographic performance, rather than highest ionization properties. However, a single generic approach for a large number of different compounds is not likely to produce good results for all compounds. Preferably, at least two or three different conditions are needed for the coverage of a larger number of structurally diverse compounds.
authors: Novamass Ltd, Medipolis Center Oulu, Finland.
authors: Timo
authors: T
authors: Rousu
authors: Juho
authors: J
authors: Hokkanen
authors: Olavi R
authors: OR
authors: Pelkonen
authors: Ari
authors: A
authors: Tolonen
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Oct 25;825(2):134-43
references: 16002352
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 1;847(2):182-7
references: 17095304
references: J Mass Spectrom. 2003 Apr;38(4):357-72
references: 12717747
references: Rapid Commun Mass Spectrom. 2004;18(1):49-58
references: 14689559
references: Anal Chem. 2008 Dec 1;80(23):9343-8
references: 19551950
references: Rapid Commun Mass Spectrom. 2005;19(6):843-8
references: 15723446
references: Rapid Commun Mass Spectrom. 2005;19(10):1359-62
references: 15852452
references: Rapid Commun Mass Spectrom. 2002;16(15):1501-5
references: 12125028
references: J Chromatogr A. 2009 Jan 23;1216(4):685-99
references: 18799161
references: Rapid Commun Mass Spectrom. 2001;15(2):141-51
references: 11180543
references: Rapid Commun Mass Spectrom. 2002;16(3):212-9
references: 11803543
references: J Sep Sci. 2006 Nov;29(16):2421-32
references: 17154122
references: Mass Spectrom Rev. 1999 May-Aug;18(3-4):187-279
references: 10568041
references: J Am Soc Mass Spectrom. 2002 Jan;13(1):2-9
references: 11777196
references: J Pharm Biomed Anal. 2007 Jul 27;44(3):665-73
references: 17236736
references: J Chromatogr B Biomed Sci Appl. 1998 May 29;709(2):243-54
references: 9657221
references: Rapid Commun Mass Spectrom. 2006;20(4):544-52
references: 16419023
references: J Pharm Biomed Anal. 2004 Jan 27;34(1):215-9
references: 14738936
references: Curr Drug Metab. 2006 Dec;7(8):837-52
references: 17168686